Market Closed -
Other stock markets
|
Pre-market 07:48:47 am | |||
156.8 USD | -0.90% | 157.2 | +0.27% |
Mar. 18 | Clearside Biomedical Names Victor Chong Chief Medical Officer | MT |
Mar. 18 | J&J: will present data in lung cancer | CF |
Financials (USD)
Sales 2024 * | 88.28B | Sales 2025 * | 90.69B | Capitalization | 378B |
---|---|---|---|---|---|
Net income 2024 * | 20.94B | Net income 2025 * | 22.33B | EV / Sales 2024 * | 4.12 x |
Net cash position 2024 * | 14.08B | Net cash position 2025 * | 27.24B | EV / Sales 2025 * | 3.87 x |
P/E ratio 2024 * |
17.6
x | P/E ratio 2025 * |
16.6
x | Employees | 131,900 |
Yield 2024 * |
3.14% | Yield 2025 * |
3.29% | Free-Float | 77.04% |
Latest transcript on Johnson & Johnson
1 day | -0.90% | ||
1 week | -2.77% | ||
Current month | -2.86% | ||
1 month | +0.13% | ||
3 months | +0.85% | ||
6 months | -3.51% | ||
Current year | +0.01% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.01% | 227 M€ | +9.20% | - | |
12.91% | 18 M€ | +5.16% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 156.8 | -0.90% | 6,602,255 |
24-03-15 | 158.2 | -0.65% | 13,165,500 |
24-03-14 | 159.2 | -1.17% | 6,988,264 |
24-03-13 | 161.1 | -1.01% | 6,260,000 |
24-03-12 | 162.7 | +0.94% | 8,018,736 |
Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.01% | 378B | |
+30.83% | 687B | |
+30.96% | 595B | |
+15.18% | 316B | |
+11.39% | 308B | |
+0.78% | 211B | |
-6.09% | 208B | |
-2.92% | 203B | |
-3.72% | 157B | |
-5.94% | 145B |